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Chicken immune responses to human proteins are often more robust than rodent
responses because of the phylogenetic relationship between the different species. For
discovery of a diverse panel of unique therapeutic antibody candidates, chickens therefore
represent an attractive host for human-derived targets. Recent advances in monoclonal
antibody technology, specifically new methods for the molecular cloning of antibody genes
directly from primary B cells, has ushered in a new era of generating monoclonal antibod-
ies from non-traditional host animals that were previously inaccessible through hybridoma
technology. However, such monoclonals still require post-discovery humanization in order
to be developed as therapeutics. To obviate the need for humanization, a modified strain
of chickens could be engineered to express a human-sequence immunoglobulin variable
region repertoire. Here, human variable genes introduced into the chicken immunoglobulin
loci through gene targeting were evaluated for their ability to be recognized and diversi-
fied by the native chicken recombination machinery that is present in the B-lineage cell
line DT40. After expansion in culture the DT40 population accumulated genetic mutants
that were detected via deep sequencing. Bioinformatic analysis revealed that the human
targeted constructs are performing as expected in the cell culture system, and provide a
measure of confidence that they will be functional in transgenic animals.
Keywords: gene conversion, somatic hypermutation, DT40, antibody repertoire, chicken B cells, human antibodies,
deep sequencing
INTRODUCTION
Historically, therapeutic monoclonal antibodies have been derived
from immunized mice and phage display technologies. However,
antigens that are conserved throughout mammalian evolution are
typically weakly or non-antigenic in mice. In some cases, the fail-
ure to elicit an immune response in mice has been obviated by
immunizing chickens (1–3). Early attempts to use chicken-derived
antibodies were thwarted by the lack of technology to derive mon-
oclonal antibodies from non-murine animals. A fusion partner
for chicken B cells was identified to create an avian version of
the classical murine hybridoma technology (4) although it has
not gained wide usage and phage display has been used more
frequently to isolate chicken monoclonals (5–11). We developed
technology to isolate antigen-specific monoclonal antibodies from
immunized chickens using a single lymphocyte screening and
recovery method, the gel-encapsulated microenvironment (GEM)
assay (see US Patents 8030095 and 841517382). The GEM assay
involves placing a single antibody-secreting lymphocyte in prox-
imity with reporters (which can be cells or beads). The secreted
antibody diffuses locally within the GEM and has the opportunity
to bind to the reporters. Bound antibody can be detected either
directly through the use of a secondary antibody or by eliciting a
response in the reporter that generates a visual signal. Each GEM
may contain multiple types of reporters which can be differenti-
ated from each other based on color. Selected GEMs are isolated
and antibody genes are amplified through RT PCR and cloned into
a mammalian expression vector, usually in scFv format.
The advantage of producing antibodies to conserved epitopes
in chickens prompted the development of humanization protocols
to obviate the immune response in patients to the avian V regions
of chimeric antibodies (7, 8). An alternative approach to eliminat-
ing the anti-animal response in patients is to engineer the animal to
produce human immunoglobulins (12). We are currently creating
a line of chickens that will produce antibodies with fully human
V regions. Human V regions will be recovered from these birds
using GEMs. We will then combine the human V segments with
human constant regions to produce fully human antibodies with
therapeutic potential. The human V region sequences have been
designed to replace the equivalent chicken coding regions while
leaving most of the endogenous IgH and IgL regulatory sequences
intact.
Diversification of chicken immunoglobulin genes is achieved
through gene conversion (GC) and somatic hypermutation
(SHM) (13). In humans, diversification is achieved through V(D)J
recombination and SHM. Because of the phylogenetic distance
between humans and chickens and the known differences in the
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mechanism of diversity generation, it was prudent to evaluate the
genetically modifiedV regions in vitro before investing in the much
longer timeline to produce genetically modified birds.
A preliminary evaluation of expression and diversification of
human immunoglobulin V regions in DT40 cells was previously
reported (14). Briefly, chicken VL and VH loci were knocked out
in DT40 and replaced with human VK (VK3-15) and VH (VH3-
23) genes. To achieve GC of human genes in chicken B cells,
human pseudogene arrays were inserted upstream of the func-
tional human VK and VH regions. The sequences of the VK and VH
functional genes served as the starting template for the design of
the human pseudogenes. Proper expression of chimeric IgM com-
prises human variable regions and chicken constant regions were
shown. Sanger-based sequencing of selected DT40 genetic variants
confirmed that the human pseudogene arrays contributed to the
generation of diversity through GC at both the Igl and Igh loci.
Although these data showed that engineered pseudogene arrays
contribute to human antibody sequences in chicken B cells, a more
thorough repertoire analysis was not possible as only a relatively
small number of events were analyzed.
Here, we have used next-generation sequencing methods to
study much more comprehensively the repertoire generated by a
long-term, non-selected culture of DT40 cells harboring targeted
human V genes, analyzing well over 1 million sequences for each
of the heavy and light chains. We are now able to show that the
engineered locus can produce a diverse pool of human antibody
sequences in chicken B cells.
MATERIALS AND METHODS
CULTURE OF CHICKEN DT40 CELLS CARRYING HUMAN V GENES
A derivative of the chicken B cell line DT40 was made in which
the chicken immunoglobulin variable regions were replaced with
human variable regions in both the IgL and IgH loci (14). In both
loci, the active functional allele was targeted, thereby switching the
cells from expressing normal chicken surface IgM to the expres-
sion of chimeric IgM, consisting of human variable regions and
chicken constant regions. A derivative of DT40, cell line 1208-1,
was produced by serial transfection with knockout constructs fol-
lowed by site-specific insertion of constructs for the expression of
human V regions. To take advantage of the GC machinery in DT40,
upstream arrays of human-sequence pseudogenes were included
in the transgenes to provide the donor sequences for mutating the
single functional human kappa (HuVK) and human heavy chain
(HuVH) regions (Figure 1). Pseudogene arrays were synthesized
by Bio Basic (Markham, ON, Canada). These pseudogenes were
based on the sequences of the functional HuVK and HuVH regions,
with diversity incorporated into the complementarity determin-
ing regions (CDR), and in some cases, the framework regions as
well (Figure 2). The pseudogenes were thus designed de novo and
not based on the endogenous pseudogenes found in the human
genomic heavy and light chain loci. We refer to the HuVK pseudo-
genes as the SynVK array and the HuVH pseudogenes as the SynVH
array. Diversity in the SynVK array was derived from human
EST sequences, whereas the SynVH array was made by scanning
substitution of CDR positions with tyrosine, tryptophan, or ser-
ine residues. Furthermore, additional AID hotspots (nucleotides
WRC/GYW) were incorporated into the SynVK-C construct, as
FIGURE 1 | Diagrams of light chain (A) and heavy chain (B) loci in cell
line 1208-1. (A) In the light chain, the endogenous rearranged chicken VL
and its promoter in DT40 was replaced by an array of human SynVK-C
pseudogenes and a rearranged functional HuVK gene driven by the chicken
VL promoter. The chicken ΨVL pseudogene array, constant region (Cλ), J–C
intron, and 3′ flanking DNA are intact. A β-actin-hygromycin, β-actin-
blasticidin resistance cassette (box labeled Hygro-blast) was placed
between the chicken and human pseudogene arrays as part of the
transfection process. (B) In the heavy chain, the endogenous rearranged
chicken VH and 350 bp of its promoter region were replaced by the SynVH-B
human pseudogene array, the chicken VH promoter, and a rearranged
functional human VH gene. The upstream chicken ΨVH pseudogene array,
the chicken JH-Cµ intron, and constant regions are intact. A β-actin-EGFP,
β-actin-puromycin, β-actin-neomycin selectable marker cassette (box labeled
GFP-puro-neo) was placed between the chicken and human pseudogene
arrays as part of the transfection process. Gene conversion in both heavy
and light chains is depicted as blocks of sequences (colored blocks) being
transferred from the pseudogenes to the HuVK and HuVH functional genes.
silent changes. In the 1208-1 cell line, construct SynVH-B was
inserted at the heavy chain locus, followed by insertion of the
SynVK-C construct at the light chain locus. The sequences of the
pseudogene arrays are shown in Figure 2.
The 1208-1 cell line was propagated for 10 weeks with both
SynVK-C and SynVH-B transgenes to allow mutations to accumu-
late prior to harvesting genomic DNA for sequencing (additionally,
the precursor cell line carrying only the SynVH-B construct was
cultured for 3 weeks before transfection of the SynVK-C con-
struct). The culture was expanded to 1.85e8 cells and gDNA was
purified by Qiagen DNeasy kit.
GENERATION OF AMPLICONS FOR SEQUENCING
Purified gDNA from the 1208-1 DT40 cell line was sent for further
processing to Genewiz, Inc. The HuVK and HuVH regions were
amplified using the primers in Table 1. Amplicons were sequenced
by Genewiz, Inc. (South Plainfield, NJ, USA) on the Illumina
MiSeq 2x250 platform (Illumina, Inc., San Diego, CA, USA). Raw
data files are available online at the NCBI sequence read archive
(SRA), project PRJNA275158, accession number SRP055184.
SEQUENCE DATA ANALYSIS
High throughput sequencing reads were analyzed using VDJ-
Fasta (http://www.distributedbio.com/vdjfastadocs/), a general
antibody repertoire algorithm suitable for interpretation of engi-
neered antibody diversity. In order to control for possible residual
chicken content, we used a combination natural chicken and
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FIGURE 2 | Human light and heavy chain pseudogene sequences.
(A) Alignment of SynVK pseudogenes in the SynVK-C construct. Top line
shows the sequence of the functional HuVK gene that is mutated by the
SynVK pseudogenes. The CDRs (boxes; IMGT nomenclature) were derived
from human EST databases. Some pseudogenes also contain framework
changes derived from the ESTs. At the 3′ end of the pseudogenes, the
sequence of the flanking DNA downstream of CDR3 in each pseudogene is
shown. This flanking sequence is part of the 100 bp spacer sequence inserted
between each pair of pseudogenes. (B) Alignment of the SynVH
pseudogenes in the SynVH-B construct. Top line shows the sequence of the
functional HuVH gene. The CDRs consist of a tyrosine/tryptophan/serine scan.
The framework regions contain no changes.
Table 1 | Primers for amplification of HuVK and HuVH sequences from
gDNA from 1208-1 cells.
For HuVH amplicon Sequence
HuVHampf1 (forward) TCCTTCCCCACAGGTGTC
HuVHampr1 (reverse) GGTTGAAGACTCACCTGAG
For HuVK amplicon
HuVKampf1 (forward) CAGACTGCACCGGAGAAA
HuVKampr1 (reverse) GTCAGCGACTCACGTTTG
human synthetic segment classification database. In order to ana-
lyze the repertoire comprehensively in a manner unbiased by
the underlying GC mechanics, we used general profile Hidden–
Markov models to identify immunoglobulin content and align
sequences in a consistent manner independent of nucleotide
composition. Kabat positional annotations were transferred from
Hidden–Markov model columns to every aligned sequence in the
resulting database, enabling consistent annotation of frameworks
and CDR boundaries (15–17).
RESULTS
READ QUALITY ANALYSIS
Analysis was performed by processing all reads through VDJFasta.
Sequences were assigned closest segments with a probabilistic clas-
sifier. All reads were translated into six-frames of translation and
analyzed for Ig content by profile-Hidden–Markov model scor-
ing with VDJFasta, with a 1e-10 cutoff for significance. Pass-cutoff
frames were aligned using the pHMMs and analyzed for framestate
and coverage. Over 96% of reads contained full-length clones, with
over 1 million HuVH reads and 2 million HuVK reads available for
downstream analysis (Table 2).
COMPARISON TO INSERTED ARRAYS OF V GENES
Nucleotide and translated CDRs were extracted from pro-
file Hidden–Markov model alignments, using minimum profile
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Table 2 | Analysis of on-target proportions in data.
HuVH HuVK
Reads Proportion (%) Reads Proportion (%)
Total 1117578 100.0 2066629 100.0
wV 1115812 99.8 2029766 98.2
wJ 1093284 97.8 2014189 97.5
wVJ 1093270 97.8 2014173 97.5
wVJclone 1074927 96.2 2002661 96.9
wV, contains detectable V-segment; wJ, contains detectable J-segment; wVJ,
contains both a detectable V and J segment; wVJclone, contains a detectable V
and J segment, and a CDR3 that remains in-frame.
annealing cutoffs to ensure high fidelity CDR capture [see Ref.
(15)]. CDRs were compared to a reference database containing
all V genes and pseudogenes that were included in the targeted
array. Counts of exact match to reference database were stored for
all CDRs.
SEQUENCE COMPLEXITY
The extracted sequences were highly redundant in both the heavy
chain and light chain data sets, with the single functional human
V gene being seen predominately in its respective group. The non-
mutated VK represented 81% of all the full-length sequence reads
and the non-mutated VH 57% of the total. These non-mutated
sequences are referred to as the “reference” sequences (one for VH
and one for VK). For the heavy chain, 9125 unique clones were
found at a minimum 2× sequence depth; for the light chain, 7671
unique clones were found. If the sequences are counted at a 1×
sequence depth a total of 21,403 unique heavy chains and 33,848
unique light chain genes were seen.
IDENTIFYING GENE CONVERSION AND SOMATIC HYPERMUTATION
EVENTS
Each framework and CDR was analyzed separately, with an exact-
match assignment performed to reference synthetic human frame-
works designed into the transgenic organism. A control search
was also performed with all known native IgL and IgH chicken
segments, but they were never encountered in the repertoire. GC
events were scored if a sequence found in the VK (Table 3) or
VH (Table 4) pool could be traced back to particular pseudo-
genes present in the array. In the cases where gene converted
sequences are shared by multiple pseudogenes, one GC event is
counted and all possible donor pseudogenes are indicated. Indi-
vidual GC events were counted at the 1× sequence depth since
it is unlikely that stretches of nucleotides would occur through
sequencing or read error. Regardless, all CDR events classified as
GC occurred more than twice in the data set. Within each CDR a
high proportion of the unique sequences matched perfectly with
the reference sequence. Those that deviated from the reference
sequence in ways that could not be clearly attributed to GC are
labeled as “SHM or fusion” and this category includes single or
multiple point mutations as well as possible complex events (i.e.,
multiple sequential GC). Sequencing errors would be expected to
show up in this category, possibly inflating the observed events.
Table 3 | Number of unique SHM and gene conversion sequences
within CDRs for light chain.
CDR1 Events CDR2 Events CDR3 Events
SynVK_
Reference
28735 SynVK_
Reference
17179 SynVK_
Reference
13995
SHM or
fusion
3853 SHM or
fusion
15340 SHM or
fusion
22630
SynVK20 20 SynVK20/21 160 SynVK23_
CDR3
87
SynVK21 44 SynVK22 76 Chicken
pseudo
0
SynVK22 39 SynVK24 21
SynVK23 219 SynVK26 83
SynVK24 195 SynVK27 11
SynVK25 121 SynVK28/29 203
SynVK26 52 SynVK30/31 284
SynVK27 44 SynVK32 204
SynVK28 30 SynVK33 129
SynVK29 49 SynVK34 88
SynVK30 314 SynVK35 70
SynVK31 39 Chicken
pseudo
0
SynVK32 4
SynVK33 15
SynVK34 27
SynVK35 48
Chicken
pseudo
0
Sum GC 1260 Sum GC 1329 Sum GC 87
Total 33848 Total 33848 Total 36712a
aIncludes a small proportion of non-full-length reads.
EVALUATION OF POTENTIAL CONTRIBUTION OF ENDOGENOUS
CHICKEN PSEUDOGENES
The IgL and IgH knockouts were made by deleting portions of
the functional VJC and VDJ regions, respectively, by homologous
recombination. Since endogenous chicken pseudogenes remain
upstream of the inserted human V gene array, they could in prin-
ciple contribute to repertoire diversity. We specifically checked for
such events by creating a library of all known chicken pseudogenes
and running the analysis as we did with the library containing
our human pseudogenes. Evidence of endogenous pseudogenes
participating in GC events was never observed.
GENE CONVERSION AND SHM IN FRAMEWORK REGIONS
Since some diversity was incorporated into the frameworks of the
inserted VK pseudogenes, it was possible to identify GC events
as well as SHM events in these regions (Table 5). Fewer GC
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Table 4 | Number of unique SHM and gene conversion sequences
within CDRs for heavy chain.
CDR1 Events CDR2 Events CDR3 Events
SynVH_
Reference
19440 SynVH_
Reference
5600 SynVH_
Reference
19379
SHM or
fusion
647 SHM or
fusion
15096 SHM or
fusion
1830
SynVH_21 185 SynVH_21 111 SynVH_22 13
SynVH_22 120 SynVH_22 61 SynVH_23 11
SynVH_23 39 SynVH_23 138 SynVH_24 32
SynVH_24 160 SynVH_24 3 SynVH_25 21
SynVH_25 96 SynVH_25 15 SynVH_26 20
SynVH_26 39 SynVH_26 149 SynVH_27 9
SynVH_28 79 SynVH_27 22 SynVH_28 3
SynVH_29 38 SynVH_28 28 SynVH_30 4
SynVH_30 37 SynVH_29 66 SynVH_31 20
SynVH_31 102 SynVH_30 12 SynVH_32 18
SynVH_32 101 SynVH_31 19 SynVH_37 43
SynVH_33 17 SynVH_32 4 Chicken
pseudo
0
SynVH_34 116 SynVH_33 5
SynVH_35 5 SynVH_34 48
SynVH_36 169 SynVH_35 11
SynVH_37 13 SynVH_36 15
Chicken
pseudo
0 Chicken
pseudo
0
Sum GC 1316 Sum GC 707 Sum GC 194
Total 21403 Total 21403 Total 21403
Table 5 | Number of unique SHM and gene conversion sequences
within VK framework regions.
FW1 Events FW2 Events FW3 Events
SynVK_
Reference
26576 SynVK_
Reference
17114 SynVK_
Reference
22447
SHM or
fusion
7163 SHM or
fusion
16405 SHM or
fusion
11235
SynVK22 43 SynVK24 94 SynVK23 144
SynVK25 41 SynVK27 32 SynVK25 11
SynVK26 13 SynVK28 54 SynVK27 10
SynVK27 8 SynVK29 24 SynVK30 1
SynVK30 1 SynVK33 49
SynVK31 1 SynVK34 76
SynVK33 2
Sum GC 109 Sum GC 329 Sum GC 166
Total 33848 Total 33848 Total 33848
attributable sequences were found in the VK frameworks as com-
pared to theVK CDRs; however, this may be due simply to the lower
framework diversity that was incorporated in the pseudogene
design.
IDENTIFICATION OF MULTIPLE GENE CONVERSION EVENTS
In some cases, we were able to identify sequences with contri-
butions from two different pseudogenes, and these are termed
paired-fusion events (Tables 6–8). Partial GC was analyzed using
the parsimonious assumption of single-conversion events within
the CDR as a source of non-100% identity match to the SynVH
pseudogene segment reference database. Custom software was
written to generate all non-redundant fusion events that can
emerge between pairwise interactions of the reference database
sequences. Paired-fusion events are highly biased in their relative
Table 6 |Top 10 most common HuVH CDR-H1 paired-fusion events.
FREQ
67 SynVH_22_CDR_1 invades>SynVH_21_CDR_1 at position 2
21 SynVH_25_CDR_1 invades>SynVH_21_CDR_1 at position 13
17 SynVH_21_CDR_1 invades>SynVH_28_CDR_1 at position 3
13 SynVH_22_CDR_1 invades>SynVH_29_CDR_1 at position 1
12 SynVH_27ref_CDR_1 invades>SynVH_36_CDR_1 at position 22
11 SynVH_21_CDR_1 invades>SynVH_27ref_CDR_1 at position 1
10 SynVH_25_CDR_1 invades>SynVH_32_CDR_1 at position 11
8 SynVH_23_CDR_1 invades>SynVH_21_CDR_1 at position 7
7 SynVH_27ref_CDR_1 invades>SynVH_37_CDR_1 at position 20
6 SynVH_36_CDR_1 invades>SynVH_21_CDR_1 at position 23
Table 7 |Top 10 most common HuVH CDR-H2 paired-fusion events.
FREQ
4304 SynVH_26_CDR_2 invades>SynVH_29_CDR_2 at position 13
1381 SynVH_21_CDR_2 invades>SynVH_32_CDR_2 at position 10
562 SynVH_26_CDR_2 invades>SynVH_29_CDR_2 at position 13
318 SynVH_21_CDR_2 invades>SynVH_30_CDR_2 at position 4
185 SynVH_28_CDR_2 invades>SynVH_27_CDR_2 at position 19
115 SynVH_21_CDR_2 invades>SynVH_32_CDR_2 at position 10
80 SynVH_21_CDR_2 invades>SynVH_31_CDR_2 at position 7
78 SynVH_23_CDR_2 invades>SynVH_29_CDR_2 at position 13
49 SynVH_22_CDR_2 invades>SynVH_29_CDR_2 at position 13
41 SynVH_CDR_2 invades>SynVH_21_CDR_2 at position 23
Table 8 |Top 10 most common HuVH CDR-H3 paired-fusion events.
FREQ
204 SynVH_21_CDR_3 invades>SynVH_35_CDR_3 at position 20
153 SynVH_21_CDR_3 invades>SynVH_24_CDR_3 at position 10
39 SynVH_21_CDR_3 invades>SynVH_36_CDR_3 at position 23
30 SynVH_21_CDR_3 invades>SynVH_27_CDR_3 at position 19
21 SynVH_37_CDR_3 invades>SynVH_21_CDR_3 at position 14
13 SynVH_27_CDR_3 invades>SynVH_21_CDR_3 at position 19
8 SynVH_24_CDR_3 invades>SynVH_21_CDR_3 at position 10
7 SynVH_36_CDR_3 invades>SynVH_21_CDR_3 at position 23
7 SynVH_22_CDR_3 invades>SynVH_21_CDR_3 at position 4
6 SynVH_25_CDR_3 invades>SynVH_21_CDR_3 at position 14
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FIGURE 3 | Positional weight matrices of non-reference residue variation, by Kabat position. (A) HuVK variation, indicated positionally. (B) HuVH variation,
indicated positionally.
occurrence, as an analysis of the most commonly encountered
rearrangements demonstrates. Paired-fusion events were not fea-
sible to determine for SynVK due to the sequence complexity
inherent in this array.
POSITIONAL VARIATION PROFILING OF THE REPERTOIRE
Analysis of positional amino acid variation was performed by con-
verting a total alignment of non-redundant amino acid sequences
into a positional weight matrix (PWM), with reference residue
frequency omitted to emphasize non-reference residue variation
(Figure 3). The number of amino acids observed at each posi-
tion cannot be attributed to GC events including both complete
replacements and single paired fusions. These observations suggest
that the diversity generated by GC is augmented by SHM.
DISCUSSION
The DT40 cell line has been used extensively to better understand
the nature of immunoglobulin diversification in chickens, includ-
ing the mechanism of GC (18–21). The cell line has also been used
to develop chicken antibodies to novel targets using in vitro selec-
tion strategies (22, 23). We have inserted human V gene arrays
into the chicken immunoglobulin loci of DT40. In principle, the
human V genes in DT40 cells could be diversified in vitro to pro-
vide an unselected library of immunoglobulin sequences from
which antigen-specific antibodies could be extracted. However,
most therapeutic antibodies are derived from immunized ani-
mals producing affinity-matured, antigen-specific antibodies. In
the current context, we have used DT40 cells to provide in vitro
proof of concept that arrays of human-derived immunoglobu-
lin gene sequences can be diversified by chicken B cells. Sub-
sequently, these sequences will be introduced into chickens to
provide genetically engineered animals that can be immunized to
produce affinity-matured, antigen-specific antibodies with ther-
apeutic potential. Thus, our purpose with DT40 is to determine
whether targeted synthetic human V gene arrays can be used as a
substrate for genetic diversification in chicken cells in a way that
mirrors what is known regarding the native chicken immunoglob-
ulin loci. Affirmative data in the DT40 culture system inspires
confidence that the effort required on the arduous path to gen-
erating a genetically engineered chicken will be rewarded with a
transgenic animal that performs as expected.
We have previously shown that our heavy and light chain arrays
can be diversified by both GC and SHM in DT40 cells (14). This
analysis involved conventional sequencing of a few hundred clones
sampled from a large population of DT40 cells. Some examples of
expected diversification events were seen, but most events were
likely missed at that depth. Next generation sequence technol-
ogy allows for identification of very rare events in a non-selected,
Frontiers in Immunology | B Cell Biology March 2015 | Volume 6 | Article 126 | 6
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Leighton et al. Human antibodies diversified in chicken
non-biased cellular population. Indeed, we were able to show in
the current work that every pseudogene in our array was used by
some cell in the population. The finding of paired-fusion events,
wherein GC occurs using two different pseudogenes in succession
is expected in a fully functional locus. It has been estimated that
wild-type chicken B cells undergo 1–2 independent GC events on
average during affinity maturation (24).
We were also able to confirm our previous conclusion that
for both heavy and light chains, GC is more prevalent in CDR1
and CDR2 than CDR3, which is heavily skewed toward SHM.
This finding is also consistent with previously published results
(25). Nonetheless, a mix of both templated and non-templated
mutations is seen in all CDRs, resulting in a repertoire with amino
acid diversity at every CDR position. It will be interesting to see if a
similar bias can be seen in the SynV chicken, in which processes of
cellular selection may affect the repertoire in a way that is not seen
in DT40, which has no selection pressure for surface Ig expression
or specificity.
While it is reasonable to use deep sequencing on our DT40
population to determine whether certain types of events have
occurred, caution should be used in interpreting the observed
frequency results because of the nature of the long-term DT40
culture system. In such a system, clones with particular sequences
could have a growth advantage, or alternatively, a particular muta-
tion could occur very early in the expansion of the culture and
then subsequent mutations could occur in addition, potentially
creating a large number of “unique clones,” which carry the orig-
inal mutation. For instance, in our VHCDR2 data, we find a very
large number of clones bearing a S53R substitution (Figure 3).
The high frequency observed could be the result of a true muta-
tional hotspot that mutated many times independently, or simply
the result of a single random mutation that occurred early in the
expansion of the population. One sequence bearing this substitu-
tion is highly redundant in our sample, second only to the starting
sequence; this is consistent with the existence of a large subpopu-
lation wherein secondary mutations could have occurred. Further,
if S53R is an aberration, it skewed our data to make it appear that
SHM in HC CDR2 is extremely high relative to GC, which may
not be the correct interpretation.
In summary, the DT40 culture system, coupled with deep
sequencing methodologies, is an excellent tool for the functional
testing of arrays of synthetic human V genes designed to be diver-
sified and affinity-matured in vivo. Our deep sequencing results
confirm that arrays of human V genes can be targeted into the
immunoglobulin loci of chicken cells and the host machinery
can diversify those genes over time in a manner that recapitu-
lates in vivo GC in the B cells of wild-type chickens. Furthermore,
when rare events are included in the analysis, it is clear that even in
a relatively small population of cells, all of the introduced pseudo-
genes are capable of participating in GC, and that codons for
non-templated amino acid residues are generated through SHM
in every CDR of both light chain and heavy chain. These data
support the concept of introducing constructs containing all nec-
essary genetic elements required for diversification in the B cell
compartment, contributing to a functionally diverse repertoire of
human-sequence antibodies in a transgenic chicken. Once made,
this bird will be the most evolutionarily divergent host of any
human-Ig transgenic animal currently available, and will be par-
ticularly well suited to generating novel antibodies to therapeutic
targets that are conserved among mammals.
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